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SUMMARY: To identify the genes responsible for blood pressure in the 
spontaneously hypertensive rat strain, we performed a cosegregation analysis 
between the genotype and blood pressure in a set of male F2 rats obtained by 
crossmating SHR with Wistar-Kyoto rats, a parental normotensive strain. Our 
investigation revealed that the phospholipase C-61 polymorphism, which 
resulted in missense mutation, cosegregates with the lower blood pressure in 
SHR, and that PLC-61 gene is located on chromosome 8. On the other hand, 
we found the lack of cosegregation between blood pressure and the nerve 
growth factor receptor gene, which is linked to a hypertensinogenic gene locus 
(denoted as BP/SP- 1) on chromosome 10. We propose that PLC-61 gene itself 
or closely linked gene on chromosome 8 is a new candidate with the 
hypotensive effect, and that BP-SPl locus does not directly contribute to blood 
pressure elevation in original SHR. 0 1992 Academic Pre5.3, Inc. 
Recent advances in molecular biology have allowed the studies on 
hypertension by cosegregation analysis (l-4). Using F2 progeny of the 
spontaneously hypertensive rats (SHR) crossmated with its normotensive 
control rats, several groups have reported that specific markers of renin (5) 
and kallikrein (6) genes cosegregate with blood pressure. Furthermore, recent 
Abbreviations: SHR, spontaneously hypertensive rat; WKY, Wistar-Kyoto rat; PLC-61, 
phospholipase C-61; PLC, phosphoinositide-specific phospholipase C; NGFRR, rat 
nerve growth factor receptor. 
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studies using chromosomal mapping proposed that two genetic loci, BP/SP-1 on 
chromosome 10 with hypertensinogenic effect and BP/SP-2 on chromosome X 
with hypotensinogenic effect, cosegregated with blood pressure in SHRSP (7-9). 
However, biometric analysis suggests that the blood pressure is a polygenic trait 
and that the previously reported genes cannot explain all the variations in blood 
pressure, and it was not evident that these loci associate with blood pressure in 
the original SHR strain. 
Recently, we discovered novel point mutations in the phospholipase C-61 
(PLC-61) gene in hypertensive rats (SHR and SHRSP), but not in control 
normotensive rats, which cause amino acid substitutions in a putative catalytic X 
domain (10). Phosphoinositide-specific phospholipase C (PLC) is a key enzyme 
that regulates the signal transduction system and intracellular calcium handling 
(11). It is widely agreed that both intracellular calcium and PLC activity 
increase in SHR (12-14). It has been hypothesized that elevated PLC activity 
facilitates augmentation of cytosolic calcium concentration, enhancing vascular 
smooth muscle tension and thus inducing hypertension. 
In this study, we used a set of F2 rats obtained by crossmating the original 
SHR with WKY. Using a new set of F2 progeny, we investigated the 
cosegregation of directly measured blood pressure with the PLC-61 mutation 
polymorphism, and that with previously reported NGFRR using a microsatellite 
marker, which is mapped as being most closely linked to the locus of BP/SP-1 
gene (7). 
MATERIALS AND METHODS 
Desipn of Genetic Crosses 
Crosses were made between 3 male SHR (191.5&l .9mmHg) and 3 female 
WKY rats (128.3+0.8mmHg) in the Laboratory Animal Science and 
Toxicology Laboratories, Sankyo Co., Ltd., Shizuoka, Japan. We confirmed 
that these substrains were genetically inbred by fingerprint analysis (15). The 
FI hybrid was intercrossed for the study of F2 segregating generation. 
Animal Maintenance 
All rats were housed under identical environmental conditions at the 
temperature of 24fl°C, humidity of 55+5% and a 12 hour dark-light cycle and 
were fed by commercial pellet CE-2 (Japan Clea Co. Ltd.). 
Blood Pressure Measurements 
A catheter was implanted into the abdominal aorta through a femoral artery 
under light ether anesthesia at 15 weeks of age. Systolic and diastolic blood 
pressure and heart rate were measured three times at a 24 hour interval after 
catheterization, while the animals were quite at rest and in a freely mobile state. 
The measurements were carried out using a pressure transducer (TP-400T), 
monitors (AT-601G and AT-641 G) and a recorder (RTA- 1300), all from 
Nihon Koden Co. Ltd. During the measurements, animals were shielded from 
the observer. 
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Genetic Typing by PCR 
The genomic DNA samples were extracted from rat livers (16). Primers of 
PLC-61 were designed to amplify the region flanking the mutation. The 
forward primer (5’-3’) was CCTGGAGAACCACTGTAGCC, and the reverse 
primer (5’-3’) was CTCCCAGCTTCTTCCCTTTCA. Sample DNA was 
amplified in 50mM Tris, pH8.5, 1mM MgC12, 20mM KCl, 500ug/ml BSA, 
200uM dNTP and 1OuM of each primer. Samples were denatured for 60sec at 
94°C and then cycled 30 times through the following steps: 1 Ssec at 94”C, 15sec 
at 55°C and then 45sec at 72°C. All PCR were performed in a lop,1 reaction 
volume enclosed into glass capillary tubes using the Air Thermo-Cycler (Idaho 
Technology Co.). PCR products digested by XhoI were electrophoresed on 2% 
agarose gel. The presence of Xhol site in PLC-61 gene divided F2 progeny into 
following 3 groups: homozygote with mutation, +/+, heterozygous mutation, 
+/-, and homozygote without mutation, -/- (Fig. 1). 
The genotyping of NGFRR gene was determined according to the same 
protocol of Hilbert et al. (7). The differences of the number of CA repeats 
divided Fz progeny into 3 groups: SHR/SHR, SHR/WKY and WKY/WKY. 
Data Analvsis 
Analysis of variance (ANOVA) was conducted utilizing the program 
package, Stat View (Abacus Concepts, Inc.). 
Chromosomal assignment 
Eighteen rat X mouse somatic cell hybrids (YSOl-18) were produced by 
fusing thymus cell of an ACI/N male rat with mouse myeloma, Sp2/0-Ag14 
cells. This panel was used to assign PLC-61 locus to a rat chromosome. 
Distribution of rat chromosomes in this hybrid panel was reported previously 
(17, 18). Using primers designed to amplify the region flanking the mutation, 
we amplified a rat specific PLC-61 sequence in hybrid clones. Amplifications 
of rat specific PLC-81 sequence in the hybrid clones were scored according to 
whether they were amplified or not and were compared to the segregation 
patterns of individual rat chromosomes in the clone panel. 
RESULTS 
We previously reported two missense mutations and several silent 
mutations in the PLC-81 gene of SHR and SHRSP (10). One missense mutation 
(Thr to Ser) located in X domain was proposed to affect the activity of the 
enzyme by changing the conformation or the phosphorylation pattern of the 
domain. This mutation in PLC-61 gene can clearly be detected by digestion of 
the polymerase chain reaction (PCR) products with XhoI. The presence of 
XhoI site in PLC-61 gene divided F2 progeny into following 3 groups: 
homozygote with mutation, +/+, heterozygous mutation, +/-, homozygote 
without mutation, -/- (Fig. 1). As shown in Table 1 and Fig. 2, we found that 
the PLC-61 polymorphism as determined above significantly cosegregated with 
lower systolic (~~0.01) and mean (~~0.05) blood pressure in SHR. Though the 
BP/SP-1 gene was proposed to have a dominant effect in the F2 population of 
SHRSP, the PLC-61 mutation allele was revealed to have a co-dominant 
1361 
Vol. 187, No. 3, 1992 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
vlu L I 
FO Fz progeny 
Fiswre 1. Genotypes of SHR, WKY and F2 progeny determined by 
PCR-RFLPs for the presence of XhoI site in the PLC-61 gene. 
+ symbol indicates that this allele has XhoI site, the SHR specific mutation 
site causing a Thr to Ser amino acid substitution (10). - symbol indicates that 
the allele is not digested with XhoI. The SHR strain is homozygous for XhoI 
restriction site and gives rise to fragments of 145bp and 103bp. The PCR 
product from WKY gives only the 248bp fragment. The FZ progeny was either 
homozygous for the SHR allele, +/+, heterozygous for the SHR and WKY 
alleles, +/-, or homozygous for the WKY allele, -/-. 
inheritance in SHR. Furthermore the rat X mouse somatic cell hybrid panel 
assigns the PLC-61 locus to the chromosome 8 with highest concordance of 
segregation patterns (Table 2). 
On the other hand, we carried out a cosegregation analysis to find out 
whether the genotype of the NGPRR gene associated with blood pressure in our 
F2 progeny. However, we failed to find a significant cosegregation between 
them (Table 1). 
Table 1. Statistics and analysis of variance on blood pressure 
measurements(mean+S.D. mmHg) by genotype in the Fz population 
PLC-61 
Genotype: +I+ +I- -I- ANOVA 
Phenotvue n=33 n=5 1 n=22 
Systolic BP 153.8&l 1.8 158.9+11.4 164.3f13.1 F2,103=5.1 
Diastolic BP 112.5k9.5 113.91t7.2 117.8k9.3 Fz.to3=2.7 
Mean BP 126.3f9.8 128.9k7.9 133.3+10 F2.103=4.0 
The genotype in the PLC-61 indicates the presence of the missense mutation. 
Statistics for ~~0.05 are indicated in bold, and for ~~0.01 are double underlined. 
NGFRR 
Genotype: SHR/sHR SfwJQ- WKY/WKY ANOVA 
PhenOtVDe n=32 n=41 n=33 
Systolic BP 157.3k12.8 159.9k12.0 157.6k12.5 F2,103=0.5 
Diastolic BP 113.6f8.8 116.0f8.4 112.8f8.3 F2.103=1.5 
Mean BP 128.2k9.6 130.6k9.2 127.7f9.1 F2.103=1.1 
The NGFRR genotype was examined according to the reported protocol (7). 
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Figure 2. Distribution of the systolic blood pressure in F2 progeny 
classified according to the PLC-61 genotype. 
The meaning of + and - symbols is as shown in Fig. 1. An asterisk indicates 
a statistical difference between +/+ and -/- (p<O.Ol). The systolic blood 
pressure of F2 progeny with homozygous SHR specific mutation was IOmmHg 
lower than that of F2 populations without the mutation. 
DISCUSSION 
We used the SHR and WKY rats in Sankyo Co. strain for genetic crosses. 
Crosses were made between male SHR and female WKY rats. F2 progeny was 
not influenced by the genes responsible for blood pressure on sex chromosome 
(for example, BP-SP2), because all F2 progeny used for this analysis were male 
rats with Y chromosome derived from male SHR and X chromosome derived 
from female WKY or male SHR in the same ratio. We measured blood 
pressure of all F2 rats directly without sodium loading, because SHR has been 
reported to be far less sensitive to salt loading compared to SHRSP (19). 
The PLC superfamily comprises at least four sub-families each of which has 
isozymes (20). Little is known about the functional differences or interactions 
among these isozymes. Although the 6 isoform of PLC is supposed to function 
in thrombin-mediated signal transduction (21), the exact function of PLC-61 
has not yet been elucidated. Interestingly, Kato et al. recently found that both 
the PLC-61 mRNA level and the enzymatic activity in aorta increased in 
proportion to the extent of blood pressure elevation (22). It should be noted 
that contrary to our original expectation, the PLC-61 allele is inversely linked 
to the blood pressure values in the F2 progeny. Further investigation is needed 
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Table 2 
(a) Distribution of rat chromosomes in hybrid clones 
Clone number (YSOI-18) 
Rat chr. no. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1 +-+-+-------f---+- 
2 + (-) - - (-) + - - _ (-) _ - _ _ _ - _ _ 
3 +++++--- +++-+- i-ii- 
4 ++-+-.-++-.-f-. + + + 
5 +++++- +++---+-++-- 
6 ---------++------- 
7 ---+-+--++-- +++-++ 
8 ---+-+--+-f--++-++ - 
9 _ - - (-, + + - f (-) - - - f f + - * + 
10 +------f---------+ 
11 +++++-I-+-++- +++++++ 
12 -+---+..-+--++- + + + 
13 +++---+---+- ++++-+ 
14 ++++-+--++- +++--+- 
15 -++++------++- + + + 
16 1 + (-) - (-) + + - +++- +f+++- 
17 + - + (-) + - (-) - + + + - + + - + + + 
18 +-+--+---++-- - (-) - + + 
19 _ - 
20 
-(-)*---+---‘~I~;~ 
+-+-+---i---f _ 
X ++*+++--++-- +-ii+++ 
Y _ - _ _ f - - - + + - + - _ * +L 
PLc-61* - - - + - + - + - + - - + + - + + 
Chromosome: +, present in 50% ceils; +, present in 20-50% cells; 
(-), present in < 20% cells; -, present in 0% 
* Amplification of rat specific sequence: +, amplified; -, unamplified 
(b) Numbers of hybrids, which showed discordance between 
segregation of rat chromosomes and amplification of a rat specific 
PLC-61 sequence in rat X mouse somatic cell hybrid clones 
Gene 1 2 3 4 5 6 7 8 9 10 I1 12 I3 14 15 16 17 18 19 20 X Y 
PLC-61 11 8 10 9 13 8 3 0 6 9 10 8 IO 9 8 8 9 7 8 9 8 8 
to find whether this isozyme itself functions as a hypotensive factor or an 
unknown gene nearby PLC-61 locus is responsible for lower blood pressure on 
chromosome 8. However, this PLC-61 locus is evidently a new candidate 
associated with lower blood pressure in original SHR other than BP-SP2 locus 
on chromosome X. 
We hypothesize that PLC-61 mutation occurred while SHR were produced 
from WKY. Recalling that the original process adopted in the selection of the 
SHR strain from WKY (23), where a significant elevation in the blood pressure 
of the strain was observed only after the passage of three generations, we can 
conclude that this major change occurred, therefore, during a very short period 
of time in contrast to the production of other hypertensive rat strains. During 
this short time period, several genes associated with blood pressure underwent 
changes, some causing major blood pressure elevation while others acting to 
suppress these otherwise lethal effects. Therefore, we inferred that PLC-61 
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gene itself or nearby linked gene on chromosome 8 changed to lower blood 
pressure during this period. Obviously further study is necessary to explain the 
actual function of the PLC-61 gene in the development of hypertension in SHR 
and possibly in human essential hypertension. 
On the other hand we failed to find cosegregation between genotype of 
NGFRR, which is a microsatellite marker located close to BP-SPl, and blood 
pressure using our F2 progeny. This means that the BP/SP-1 could be a gene 
responsible for salt sensitive blood pressure elevation, consistent with the report 
by Jeunemaitre et al. who found no linkage between the human angiotensin 
converting enzyme gene and essential hypertension without sodium loading in 
humans (24). We propose here that BP-SPl locus does not directly contribute 
to blood pressure elevation in SHR, or that this locus in SHRSP has the effect 
merely for further augmentation of the blood pressure in SHR. 
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